← FDA Drug Approvals (Drugs@FDA)

DUOBRII

NDA · New Drug Application · Sponsor: BAUSCH · Approved 2019-04-25

Drug application

FDA Application #

NDA209354

Application type

New Drug Application

Brand name

DUOBRII

Generic name

HALOBETASOL PROPIONATE AND TAZAROTENE

Active ingredients

HALOBETASOL PROPIONATE; TAZAROTENE

Dosage form

LOTION

Route

TOPICAL

Marketing status

Prescription

Sponsor

BAUSCH

Manufacturer

Bausch Health US, LLC

First approval

2019-04-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown